Literature DB >> 3873216

Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species.

R M Fliegelman, R M Petrak, L J Goodman, J Segreti, G M Trenholme, R L Kaplan.   

Abstract

The in vitro susceptibility of 27 Campylobacter jejuni, 31 Campylobacter coli, and 30 Campylobacter fetus subsp. fetus strains to 12 antimicrobial agents was determined. Ciprofloxacin, a new quinoline derivative, was the most active agent tested. Antimicrobial susceptibility differed among the three species tested.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3873216      PMCID： PMC176293          DOI： 10.1128/AAC.27.3.429

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  Rapid hippurate hydrolysis method for presumptive identification of group B streptococci.

Authors:  M N Hwang; G M Ederer
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

2.  Vibrio fetus infection in man. I. Ten new cases and some epidemiologic observations.

Authors:  V Bokkenheuser
Journal:  Am J Epidemiol       Date:  1970-04       Impact factor: 4.897

3.  Hippurate hydrolysis by Campylobacter fetus.

Authors:  S M Harvey
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

4.  Deoxyribonucleic acid sequence relatedness between thermophilic members of the genus Campylobacter.

Authors:  R J Belland; T J Trust
Journal:  J Gen Microbiol       Date:  1982-11

5.  Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.

Authors:  L J Goodman; R M Fliegelman; G M Trenholme; R L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

6.  '1001' Campylobacters: cultural characteristics of intestinal campylobacters from man and animals.

Authors:  M B Skirrow; J Benjamin
Journal:  J Hyg (Lond)       Date:  1980-12
  6 in total
  18 in total

1.  Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000.

Authors:  Carole Tremblay; Christiane Gaudreau; Manon Lorange
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

2.  Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus.

Authors:  C Tremblay; C Gaudreau
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

3.  Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli with special reference to plasmid profiles of Japanese clinical isolates.

Authors:  H Sagara; A Mochizuki; N Okamura; R Nakaya
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

4.  Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.

Authors:  P Tajada; J L Gomez-Graces; J I Alós; D Balas; R Cogollos
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

5.  Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination.

Authors:  Antti Hakanen; Hannele Jousimies-Somer; Anja Siitonen; Pentti Huovinen; Pirkko Kotilainen
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

6.  Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.

Authors:  N Lachance; C Gaudreau; F Lamothe; F Turgeon
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

7.  Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland.

Authors:  H Rautelin; O V Renkonen; T U Kosunen
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 8.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

9.  Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.

Authors:  Deborah J Griggs; Leanne Peake; Margaret M Johnson; Saba Ghori; A Mott; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

10.  In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms.

Authors:  C A Benson; J Segreti; F E Beaudette; D W Hines; L J Goodman; R L Kaplan; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.